Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2004-03-24
2008-10-07
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C435S235100, C424S201100, C424S202100
Reexamination Certificate
active
07431930
ABSTRACT:
The present invention provides a classic IBDV mutant that additionally comprises virus neutralising epitopes 67 (specific for variant-E IBDV).
REFERENCES:
patent: 5632989 (1997-05-01), Snyder
patent: 5871744 (1999-02-01), Vakharia
patent: 6017759 (2000-01-01), Vakharia et al.
patent: 0887412 (2003-10-01), None
patent: 1170303 (2006-06-01), None
patent: 9526196 (1995-10-01), None
Vakharia et al., “Molecular basis of antigenic variation in infectious bursal disease virus” 1: Virus Res. Feb. 1994; 31(2): 265-73.
Muller et al, “Research on infectious bursal disease-the past, the present and the future,” Veterinary Microbiology, 2003.
Jackwood et al., “Molecular identification of infectious bursal disease virus strains,” Avian Dis. Jan.-Mar. 1997; 41(1):97-104.
Dormitorio et al., “Sequence comparisons of the variable VP2 region of eight infectious bursal disease virus isolates,” Avian Dis. Jan.-Mar. 1997;41(1):36-44.
Jackwood et al., “Identification and comparison of point mutations associated in classic and variant infectious bursal disease viruses,” Virus Res. Jun. 1997;49(2):131-7.
Whetzel et al., “Comparison of neutralizing epitopes among infectious bursal disease viruses using radioimmunoprecipitation,” 1: Avian Dis. Jul.-Sep. 1995;39(3):499-506.
Eterradossi et al., “Critical amino acid changes in VP2 variable domain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses,” Arch Virol 143, pp. 1627-1636 (1998).
Yu et al., “Molecular characteristics of full-length genomic segment A of three infectious bursal disease viruses in China: two attenuated strains and one virulent field strain” Avian Dis. Oct.-Dec. 2001;45(4):862-74.
Boot et al (Journal of Virological Methods 97:67-76, 2001).
Mundt (Journal of General Virology 80:2067-2076, 1999).
Lim et al (Journal of Virology 2854-2962, 1999).
Bayliss, C.D., et al. (1990). A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. Journal of General Virology, 71:1303-1312.
Bayyari, G.R., et al. (1996). Pathogenicity Studies of an Arkansas Variant Infectious Bursal Disease Virus. Avian Diseases, 40:516-532.
Boot, H.J. et al. (2001). Comparison of RNA and cDNA transfection methods for rescue of infectious bursal disease virus. Journal of Virological Methods, 97:67-76.
Heine, H.G. et al. (1991). Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. Journal of General Virology, 72:1835-1843.
Jackwood, D.J. et al. (1997). Identification and comparison of point mutations associated in classic and variant infectious bursal disease viruses. Virus Research, 49:131-137.
Kunkel, T.A. et al. (1987). Rapid and Efficient Site-Specific Mutagenesis without Phenotypic Selection. Methods in Enzymology, 154:367-382.
Lim, B.L. et al. (1999). Adaptation of Very Virulent Infectious Bursal Disease Virus to Chicken Embryonic Fibroblasts by Site-Directed Mutagenesis of Residues 279 and 284 of Viral Coat Protein VP2. Journal of Virology, 73(4), 2854-2862.
Mundt, E. (1999). Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2. Journal of General Virology, 80:2067-2076.
Mundt, E. et al. (1995). Identification of a novel viral protein in infectious bursal disease virus-infected cells. Journal of General Virology. 76:437-443.
Mundt, E. et al. (1996). Synthetic transcripts of double-stranded Birnavirus genome are infectious. Proceedings of the National Academy of Sciences, 93:11131-11136.
Rosenberger, J.K. et al. (1985). Sentinel Bird Survey of Delmarva Broiler Flocks. Proc. 20th Natl. Meeting on Poultry Health and Condemnations. 94-101.
Snyder, D.B. et al. (1994). Active Cross-Protection Induced by a Recombinant Baculovirus Expressing Chimeric Infectious Bursal Disease Virus Structural Proteins. Avian Diseases. 38:701-707.
Snyder, D.B. et al. (1988). Differentiation of Infectious Bursal Disease Viruses Directly from Infected Tissues with Neutralizing Monoclonal Antibodies: Evidence of a Major Antigenic Shift in Recent Field Isolates. Avian Diseases. 32:535-539.
Snyder, D.B. et al. (1994). Molecular Epidemiology of Infectious Bursal Disease Virus in the United States. Proceedings of the International symposium on infectious bursal disease and chicken infectious anaemia, Rauischholzhausen, Germany. 60-70.
Snyder, D.B. et al. (1992). Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. Archives of Virology. 127:89-101.
Tsai, H.J. et al. (1992). Effect of Cell-Culture Passage on the Pathogenicity and Immunogenicity of Two Variant Strains of Infectious Bursal Disease Virus. Avian Diseases. 36:415-422.
Vakharia, V. et al. (1994). Molecular basis of antigenic variation in infectious bursal disease virus. Virus Research. 31:265-273.
van Loon, A.A.W.M. et al. (1994). Rapid Quantification of Infectious Bursal Disease (IBD) Challenge, Field or Vaccine Virus Strains. Proceedings of the International symposium on infectious bursal disease and chicken infectious anaemia, Rauischholzhausen, Germany. 179-187.
van Loon, A.A.W.M. et al. (2002). Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. Journal of General Virology. 83:121-129.
Wang, M.-Y. et al. (2000). Self-Assembly of the Infectious Bursal Disease Virus Capsid Protein, rVP2, Expressed in Insect Cells and Purification of Immunogenic Chimeric rVP2H Particles by Immobilized Metal-Ion Affinity Chromatography. Biotechnology and Bioengineering. 67(1):104-111.
Wang, M.-Y. et al. Database EMBL ′Online! (Jul. 20, 1999). Expression, Purification, and Protection of the Recombinant Infectious bursal disease virus structural protein (VP2) produced by insect cells. Database EMBL ′Online! AF109154.
Yao, K. et al. (1998). Generation of a Mutant Infectious Bursal Disease Virus That Does Not Cause Bursal Lesions. Journal of Virology. 72(4), 2647-2654.
Ho, J.Y. et al. (1999). Expression, purification, and characterization of the infectious bursal disease virus -like particles produced by insect cells. Journal of the Chinese Chemical Society. 46:5 pp. 743-750. Publisher: Chinese Chemical Society. ISSN: 0009-4536.
Letzel Tobias
Mundt Egbert
Paul Guntram
van Loon Adriaan Antonius Wilhelmus Maria
Blackstone William M.
Intervet International B.V.
Milstead Mark W.
Mosher Mary E
LandOfFree
Infectious bursal disease virus (IBDV) mutant expressing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Infectious bursal disease virus (IBDV) mutant expressing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Infectious bursal disease virus (IBDV) mutant expressing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3992346